Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.

Yi LiHaitao LiChao SongRongli LuNenghui LiuFengyu LinDuoduo HanLingli ChenPinhua PanMinhui Dai

Published in: Disease markers (2021)

The CRP/Alb ratio can predict the risk of progression to critical disease or death early, providing a promising prognostic biomarker for risk stratification and clinical management of patients with severe COVID-19.

Keyphrases

coronavirus disease
sars cov
early onset
respiratory syndrome coronavirus
drug induced